Boston Scientific (BSX) Gross Profit (2009 - 2026)

Boston Scientific has disclosed Gross Profit across 18 years of filings, most recently posting $3.6 billion for Q1 2026.

• Gross Profit for Q1 2026 came in at $3.6 billion, up 12.59% year-over-year; the trailing twelve-month figure through Mar 2026 was $14.3 billion (up 18.31% YoY), and the FY2025 annual result was $13.9 billion, up 20.57% from the prior year.
• Gross Profit came in at $3.6 billion for Q1 2026 at Boston Scientific, down from $3.7 billion in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $3.7 billion in Q4 2025 to a low of $2.1 billion in Q1 2022.
• The 5-year median for Gross Profit is $2.6 billion (2024), against an average of $2.8 billion.
• Across the five-year window, Gross Profit climbed 3.57% in 2022 and increased 22.26% in 2025, its largest moves.
• Boston Scientific's Gross Profit stood at $2.2 billion in 2022, then grew by 15.55% to $2.6 billion in 2023, then gained by 20.01% to $3.1 billion in 2024, then advanced by 18.87% to $3.7 billion in 2025, then decreased by 1.77% to $3.6 billion in 2026.
• The last three Gross Profit figures came in at $3.6 billion (Q1 2026), $3.7 billion (Q4 2025), and $3.5 billion (Q3 2025), per Business Quant data.